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Most of the human herpesviruses can be found in semen, although the reported prevalence varies considerably
between individual studies. The frequent presence of herpesvirus in semen raises the question whether sexual
transmission of the virus could have an impact on human reproduction. Only few studies have associated seminal
shedding of herpesviruses with impaired sperm quality, reduced fertility, or reduced chances of pregnancy, whereas
most studies fail to find an association. Taken together, no firm evidence is so far linking the presence of
herpesviruses in semen to impaired human reproduction.
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It is well established that many pathogens may cause sexu-
ally transmitted diseases (STD). Examples include bacter-
ial infections with Chlamydia trachomatis, Neisseria
gonorrhoeae, and Treponema pallidum, which may impair
fertility or cause severe congenital disorders. Also viral in-
fections with herpes simplex virus type 2 (HSV-2), causing
genital herpes, or human immunodeficiency virus (HIV),
which untreated may lead to AIDS, are significant health
care issues. It is generally believed that transmission of
pathogens causing STD occurs through direct contact be-
tween mucous membranes, however accumulating reports
have indicated that several bacteria [1,2] and viruses,
including HIV [3], human papillomavirus (HPV) [4],
hepatitis B virus [5], hepatitis C virus [6], Ebola virus [7],
adenovirus [8], and various human herpesviruses (HHV)
are present in semen. This suggests that semen may also
be an important transmission route, although its precise
role can be difficult to establish. This review will focus on
herpesviruses in semen and their potential significance for
human reproduction.
The family of Herpesviridae consists of nine structur-
ally similar, large, enveloped DNA viruses, which all
share the ability to persist latently in the host cell and
give rise to recurrent infections. The HHV have been di-
vided into three subfamilies (α, β, and γ) based on both
virological and biological properties, including the type
of primary target cells and the site of latency. No studies
today have examined the individual prevalence of all* Correspondence: ph@microbiology.au.dk
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distribution, and reproduction in any mediumnine HHV in semen. The individual studies are summa-
rized in Table 1 (α- and γ-HHV) and Table 2 (β-HHV).Herpes simplex virus-1 and -2
HSV-1 and -2 are neurotropic α-HHVs. HSV-1 is pri-
marily associated with oral transmission and recurrent
oral lesions, whereas HSV-2 is the major cause of genital
herpes, although both viruses are capable of infecting
any region of the body. Primary or recurrent infections
can occur either symptomatically or asymptomatically.
The seroprevalence of HSV-1 and HSV-2 increases
with age in both Europe and the USA, reaching a plat-
eau around age 40 with a prevalence of approximately
70% for HSV-1 and 40-60% for HSV-2 in “high-risk”
populations and 20-35% for HSV-2 in “low-risk” popu-
lations [41]. The prevalence of HSV-1 is roughly simi-
lar in Europe and the USA, whereas the prevalence of
HSV-2 is considerable higher in the USA [41]. Fre-
quently, studies have not discriminated between HSV-1
and -2; in these cases, we refer to HSV-1/2. HSV-1/2 is
sexually transmissible [42], and mother-to-child trans-
mission occurs in 1:1,400-30,000 births, occasionally
causing a life threatening generalized infection in the
new-born child [43].
The prevalence of HSV-1/2 in semen varies substan-
tially between different studies (Table 1). More than half
of the studies have reported frequencies of less than 4%
in both fertile and infertile men, but particularly studies
from Greece [17] and Russia [13] find, using nested PCR
and in situ hybridization, respectively, that almost half of
the semen samples from fertility-clinic attendants containMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Presence of α- and γ-herpesviruses in human semen
Study HSV-1/2 VZV EBV HHV-8 Samples from
Aynaud et al. 2002 [9] 9% (n = 111) Male partners of females with
genital HPV lesions France
Bagasra et al. 2005 [10] A) 4.4% (n = 45) A) HIV negative
B) HIV-positive homosexual
men USA, JapanB) 87.7% (n = 73)
Bezold et al. 2001 [11] 3.2% (n = 252) 0% (n = 252) 7.1% (n = 252) 0% (n = 252) FCA Germany
Bezold et al. 2007 [12] 3.7% (n = 241) 0.4% (n = 240) FCA Massachusetts
Bocharova et al. 2007 [13] 51.7% (n = 29) FCA Russia
Chen et al. 2013 [14] 25.5% (n = 153) 3.9% (n = 153) FCA China
El Borai et al. 1997 [15] A) 24% (n = 153) A) FCA
B) Fathers Japan
B) 0% (n = 16)
Howard et al. 1997 [16] A) 25% (n = 24) A) HIV-infected men
B) Healthy sperm donors UK
B) 0% (n = 115)
Kapranos et al. 2003 [17] 49.5% (n = 113) 16.8% (n = 113) FCA Greece
Kaspersen et al. 2012 [18] HSV-1: 0.4% (n = 198)
HSV-2: 0.1% (n = 198)
0% (n = 198) 6.3% (n = 198) 0% (n = 198) Sperm donors Denmark
Kelsen et al. 1999 [19] 0% (n = 100) Sperm donors Denmark
Lisco et al. 2012 [20] A) 0% (n = 28) A) 3.5% (n = 28) Semen plasma from
A) HIV-negative men
B) HIV-positive men ItalyB) 8% (n = 50) B) 56% (n = 50)
McGowan et al. 1983 [21] 0% (n = 210) A) FCA
B) Healthy students Australia
Michou et al. 2012 [22] 29% (n = 109) 0% (n = 109) 45% (n = 109) Men from couples undergoing
IVF treatment Spain
Neofytou et al. 2008 [23] 2.3% (n = 172) 2.3% (n = 172) 40.6% (n = 172) FCA Greece
Rinaldo et al. 1992 [24] 0% (n = 116) HIV-pos. (n = 58) and HIV-neg.
(n = 58) homosexuals USA
Rintala et al. 2004 [25] 3.2% (n = 252) Fathers to be Finland
Rohde et al. 1999 [26] 3.7% (n = 241) Infertile men Germany
Thomas et al. 2006 [27] 3% (n = 33) FCA UK
Wald et al. 1999 [28] 47% (n = 15) Men with genital HSV-2
Washington
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Japan [15] found HSV-1/2 in semen from 24% of
fertility-clinic attendants, but none in semen from their
fathers. Whether these significant variations in prevalence
are due to methodological differences, or reflect a true
variation between study populations may require add-
itional analyses to solve. Out of four studies, three found
the parameters in routine sperm analyses to be normal in
sperm from HSV-1/2 positive men or in sperm exposed to
HSV-1/2 in vitro [11,23,44]. The fourth study found that
the presence of HSV-1/2 was associated with low sperm
count and poor motility [17]. Indeed, HSV-2 isolated from
the testis of a dead man has been reported infectious [45],
and one case of HSV-2 transmission through donor
semen to a recipient, who subsequently acquired a pri-
mary infection, has also been reported [42]. Moreover,
Bocharova et al. [13] have reported that HSV-2 can beinternalized into the heads of morphological normal and
motile sperm, suggesting a potential effect of HSV on
pregnancy and outcome. Other groups have not yet con-
firmed this interesting observation.
Taken together, the data so far do not suggest that HSV-
1/2 is involved in impaired fertility. Besides from a study
of transmission by insemination, the mucosa-associated
HSV-1/2 transmission makes it difficult to estimate the
risk of HSV-1/2 transmission in semen per se. If an associ-
ation with sperm heads is a general feature of HSV-2, this
might have implications for infection of the endometrium,
and warrants additional investigations to clarify.
Varicella-zoster virus
Varicella-zoster virus (VZV) is an α-herpesvirus infecting
most unvaccinated people during early childhood. Primary
infection manifests itself as a usually benign childhood
Table 2 Presence of β-herpesviruses in human semen
Study HCMV HHV-6A/B HHV-7 Samples from
Aynaud et al. 2002 [9] 6.3% (n = 111) Male partners of females with
genital HPV-lesions France
Bantel-Schaal et al. 1993 [29] 0% (n = 63) FCA Germany
Bezold et al. 2001 [11] 3.6% (n = 252) 4.0% (n = 252) 0.4% (n = 252) FCA Germany
Bezold et al. 2007 [12] 8.7% (n = 241) 3.7% (n = 241) FCA Massachusetts
Bresson et al. 2003 [30] 5.3% (n = 197) Sperm donors France
Chen et al. 2013 [14] 21.6% (n = 153) 2.0% (n = 153) FCA China
Diafouka et al. 2007 [31] 14.3% (n = 63) FCA Ivory Coast
Eggert-Kruse et al. 2009 [32] 6.5% (n = 170) Subfertile patients Germany
Erles et al. 2001 [8] A) 14.3% (n = 14) A) Normal sperm quality (SQ)
B) Abnormal SQ Germany
B) 0% (n = 43)
Handsfield et al. 1985 [33] A) 22% (n = 18) A) HCMV-positive partner
B) HCMV-negative partner USA
B) 0% (n = 42)
Howard et al. 1997 [16] A) 83.3% (n = 24) A) HIV-infected men
B) Healthy sperm donors UK
B) 3.5% (n = 115)
Kapranos et al. 2003 [17] 7.1% (n = 113) FCA Greece
Kaspersen et al. 2012 [18] 2.7% (n = 198) 13.5% (n = 198) 4.2% (n = 198) Sperm donors Denmark
Lang and Kummer 1975 [34] A) 9.4% (n = 32) A) University students/personnel
B) Patients with venereal infections
C) FCA North CarolinaB) 10% (n = 10)
C) 1.1% (n = 185)
Levy et al. 1997 [35] 2.85% (n = 70) Only CMV-IgG positive men France
Lisco et al. 2012 [20] A) 3.5% (n = 28) A) 6% (n = 28) A) 6% (n = 28) Semen plasma from
A) HIV-negative men
B) HIV-positive men ItalyB) 70% (n = 50) B) 2% (n = 50) B) 12% (n = 50)
Mansat et al. 1997 [36] 5.1% (n = 97) Sperm donors France
McGowan et al. 1983 [21] A) 2.4% (n = 170) A) FCA
B) Healthy students Australia
B) 2.5% (n = 40)
Michou et al. 2012 [22] 43% (n = 109) 8.2% (n = 109) 3.6% (n = 109) Men in couples undergoing IVF
treatment Spain
Naumenko et al. 2011 [37] A) 11% (n = 91) A) Infertile men
B) Fertile men Russia
B) 15% (n = 47)
Neofytou et al. 2009 [23] 56.9% (n = 172) 66.8% (n = 172) 0% (n = 172) FCA Greece
Rinaldo et al. 1992 [24] A) 33% (n = 58) A) HIV-pos. homosexuals
B) HIV-neg. homosexuals USA
B) 17% (n = 58)
Shen et al. 1994 [38] 32.7% (n = 217) FCA China
Sherertz et al. 1984 [39] 29.4% (n = 17) Homosexuals USA
Yang et al. 1995 [40] 33.5% (n = 248) FCA Taiwan
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sults in zoster (shingles).
Only few studies have investigated the potential pres-
ence of VZV in semen. Except for one study from Greece
[23], there is agreement that VZV is neither present in
semen from fertility-clinic attendants (Germany) [11], nor
from men of couples undergoing IVF treatment (Spain)
[22], or from healthy sperm donors (Denmark) [18].Taken together, the evidence indicates that VZV is not
present in semen, perhaps reflecting the infrequency of
VZV reactivation occurring from the ganglia rather than
immune cells.
Epstein-Barr virus
Epstein-Barr virus (EBV) is a γ-herpesvirus that is pri-
marily B-lymphotropic, although it may also infect and
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of EBV (measured by antibodies) varies in different geo-
graphic areas. When acquired in early childhood, the infec-
tion is usually asymptomatic, whereas primary infection
during puberty may cause infectious mononucleosis.
The transmission during puberty involves saliva with
high-titered EBV, but might also be transmitted through
genital secretions, probably through cell-associated EBV
[27,46]. EBV can be present in cervical cells [27] and
can be transmitted from mother-to-child in approxi-
mately 3% of EBV PCR positive mothers [47]. It has not
been reported whether the presence of EBV might im-
pair endometrium receptivity.
An association with leukocytospermia and an in-
creased mean sperm count have been reported in EBV-
positive semen samples [11,23], whereas others do not
find an impact on sperm count or motility [17]. Anyhow,
it is not known whether the prevalence of EBV in semen
of infertile and fertile men differs. Separate studies on
sperm donors and fertility-clinic attendants demonstrate
variations in prevalence between studies from 0.4 to 45%
(Table 1). A recent study found significantly increased
prevalence of EBV in semen and blood of HIV-infected
individuals. Even in cases with no detectable EBV in the
blood, EBV was present in semen suggesting compart-
mentalized reactivation [20].
In conclusion, it has not been convincingly demon-
strated that EBV in semen impairs sperm function. Esti-
mates indicate that sexual transmission is a minor route
of infection, but the demonstration of EBV in cervical
cells may warrant further investigation of a potential role
of EBV during reproduction.
Human herpesvirus 8
HHV-8, also known as Kaposi’s Sarcoma-Associated
Herpesvirus or KSAV, is a γ-herpesvirus that primarily,
but not exclusively, infects B cells. Infection with HHV-
8 is predominantly seen in certain geographic regions in
Africa and South America, but this is usually among
older adults. The infection is also observed in immuno-
suppressed individuals, but is rare in healthy individuals
from North America, North Europe and Asia. Not sur-
prisingly, most studies have therefore failed to detect
HHV-8 in sperm from healthy donors or fertility-clinic
attendants (Kaspersen et al., unpublished observation
and [11,19]). In contrast, Bagasra et al. reported HHV-8
in 2 of 45 semen samples from HIV-negative men, but
further demographic information on these men was not
provided. However, HHV-8 was found in semen samples
from 64 of 73 (88%) HIV-positive homosexual men.
HHV-8 in semen was present in both sperm and mono-
nuclear cells [10]. The prevalence of HHV-8 in previous
studies have ranged from 0 to more than 90%, which may
reflect methodological differences (including sensitivityand PCR contaminations), differences in HIV status, or
geographic and population-based differences (see ref [48],
and references herein).
Human cytomegalovirus
HHV-5 or human cytomegalovirus (HCMV) is a β-
herpesvirus to which seroconversion occurs throughout
life. Infection by HCMV is often asymptomatic, but
clinically important infections occur in immunocom-
promised individuals or in pregnant women that sub-
sequently may give birth to a child with congenital
infection. Severe congenital HCMV infection is associ-
ated with growth retardation, mental retardation, deaf-
ness, microcephaly, hepatosplenomegaly, chorioretinitis,
calcification, and neurologic impairment (for review, see
Revello and Gerna [49]).
It has been almost four decades since HCMV was first
reported in semen from American men of various pop-
ulations [50]. Since then, numerous reports on identifi-
cation of HCMV in semen from differently defined
population groups have accumulated. The majority of
these studies report a prevalence of approximately 6% in
men from Germany, North America, France, Africa,
Greece, Denmark, Australia, and Russia (Table 1). In
contrast, several studies on semen of fertility-clinic at-
tendants from China, Taiwan, Spain, and Greece, have
reported high prevalences of HCMV between 21.6% to
56.9% [14,22,23,38,40]. This could possibly be explained
by geographic variation, however another study from
Greece, also of semen from fertility-clinic attendants,
found HCMV in only 7.1% [17]. Both Greek studies
used PCR for HCMV DNA detection; the study that
detected the lower frequency even used nested PCR
[17]. Shedding of HCMV in semen is also relatively high
in homosexual men [24,39]. Howard et al. found shed-
ding of HCMV in 20 out of 24 HIV-positive, homosex-
ual men (83.3%), but only in 4 out of 115 healthy donors
(3.5%) [16].
Although one case of hematospermia has been associ-
ated with HCMV shedding [51], most groups have
found the sperm parameters to be unaffected by HCMV
[8,11,17,23,31,32,40,44], and two studies that directly
compare the prevalence of HCMV in semen from fertile
and infertile men find similar frequencies within the
two groups [37,50].
HCMV in semen may be infectious [20,24,39], and
HCMV has also been isolated from human endometrial
cells [52], suggesting a possible mechanism of direct infec-
tion of the endometrial cells by HCMV carried by sperm.
Moreover, productive HCMV infection can be obtained in
human endometrial stroma cells [53]. Since a primary
HCMV infection is associated with an increased risk for
early abortion [54,55] and congenital defects in the fetus
in general [56], HCMV in semen remains a potential risk
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quent route of infection.
Whether HCMV directly impairs sperm fertility has
been investigated by Eggert-Kruse and coworkers [32].
From subfertile couples, semen from 170 males and
endocervical material from 156 females were screened
for the presence of HCMV by nested PCR. The presence
of HCMV was not concordant between couples, empha-
sizing that sexual transmission of HCMV is not a fre-
quent route of infection. Furthermore, no significant
correlations between HCMV and semen quality or be-
tween cervical HCMV-infection and mucus quality or
female infertility factor were seen.
In conclusion, sexual transmission of HCMV is rare, but
semen may contain infectious virus with the potential of
initiating a primary infection. However, there is no evi-
dence that HCMV in semen impairs fertility [32]. Longitu-
dinal studies on pregnancy outcome in HCMV-positive
versus HCMV-negative patients are, however, lacking.
Human herpesvirus 6A/B
Closely related to HCMV, the β-herpesviruses HHV-6A
and HHV-6B are frequently examined by methods that
do not allow a distinction between the two viruses. In-
fection usually occurs in the first years of life giving rise
to the childhood disease exanthem subitum, and most
adults in the Western world are seropositive. HHV-6B
has tropism for mononuclear cells, primarily T cells, but
is usually found in saliva, which is thought to be the
major route of transmission.
Only few reports are available on the prevalence of
HHV-6A/B in human semen. Bezold et al. found the
prevalence to be 4.0% in a German population of infer-
tility patients [11] and 3.7% in a population of American
infertility patients [12]. Chen et al. found HHV-6A/B in
2.0% of infertility patients from China [14], whereas
Michou et al. detected HHV-6A/B in 8.2% of 109 men
from couples undergoing IVF treatment in Spain [22].
A slightly higher prevalence of 13.5% was seen by
Kaspersen et al. in semen from Danish sperm donors
[18] (Table 2), suggesting that the prevalence of HHV-
6A/B is not increased among patients attending a
fertility clinic. A remarkably high prevalence of 66.8%
among men attending a fertility clinic on Crete has been
reported by Neofytou et al. using nested PCR [23]. The
discrepancies in HHV-6A/B prevalence are most likely
not due to geographic or population-based differences,
since HHV-6A/B appears to be present in all the popu-
lations. The most likely explanations are therefore that
the nested PCR procedure of Neofytou et al. might be
more sensitive or was contaminated. Nonetheless, it is
clear that HHV-6A/B does not directly affect sperm pa-
rameters [11,23]. Interestingly, HHV-6A/B is associated
with the acrosome of the sperm [18], but it is notknown whether this provide a mechanism for infecting
the endometrium.
The binding of HHV-6B to the acrosome [18] suggests
that HHV-6B may be transmitted to the uterus by the
sperm, but at the same time this may argue against in-
fection of the oocyte during normal fertilization, since
the acrosome is dissolved prior to the sperm enters the
egg. Nevertheless, HHV-6A/B integrates chromosomally
at a frequency of 0.8% [57], and it remains unknown
how this integration might happen. Thus, it is expected
that PCR-based detection should identify approximately
1% of semen samples simply due to chromosomal inte-
gration of either HHV-6A or HHV-6B.
In conclusion, there is no evidence so far to indicate that
HHV-6A/B affects sperm function or other aspects of
human reproduction, although a potential role of HHV-
6A/B on the endometrium has not been resolved yet.
Human herpesvirus 7
HHV-7 is a β-herpesvirus closely related to HHV-6A
and HHV-6B. HHV-7 is usually acquired prior to age 5,
and seroprevalence in adults reaches 96% [58]. Infection
by HHV-7 is either asymptomatic or causes exanthem
subitum.
Similar to HHV-6A/B, the prevalence of HHV-7 in
semen is also based on only few publications. The preva-
lence in semen from European sperm donors or men at-
tending a fertility clinic is similar and within the range
of 0.4 to 6.0% (Table 2). HIV-positive men have a slightly
higher prevalence, which could be explained by reactiva-
tion of HHV-7 by HIV, although the increase in HHV-7
prevalence is not nearly at the same level of that seen
for HCMV [20]. HHV-7 has been detected in a small
percentage of analyzed cervical swaps [59] and in one
out of eleven analyzed placental biopsy samples [60], but
any association to human reproduction has not been
reported. Effects of HHV-7 on sperm parameters have
not been evaluated.
In conclusion, there is no evidence to link HHV-7 with
human reproduction. It cannot be excluded that HHV-7
can be transmitted sexually, but the significance of this
route, if any, is unknown at present.
Concluding comments
HSV seroprevalence has been reported higher for a
population of female fertility-clinic attendants com-
pared to a population of pregnant women [61] and high
HHV-6A/B antibody titers has been associated with a
reduced chance of pregnancy [62]. Nevertheless, the
collective set of data does not indicate an association
between herpesviruses in semen and reduced fertility.
However, if sperm-associated herpesvirus is transmissible
to the female cervix or perhaps even to the endometrium,
as has been reported for HSV-2 [42], the consequences
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leukemia inhibitory factor (LIF) cytokine is essential for
blastocyst implantation. Mouse LIF-null uteri are unre-
ceptive, yet LIF-deleted blastocysts are unaffectedly
implanted into normally functioning uteri [63]. Unex-
plained female infertility is not associated with muta-
tions in the LIF gene [64]. Hu et al. [65] have shown
that the production of LIF is partially regulated by p53
and that p53-null mice blastocyst implantation rate is
significantly reduced. Herpesviruses such as HSV-1,
HCMV, and HHV-6B have the ability to inactivate p53.
Thus, implantation of the blastocyst could hypothetic-
ally be negatively influenced by viral infection of uterus
tissue. Although the presence of HHV-6B in cells of the
endometrium has not yet been investigated, it is pos-
sible that local infection or reactivation of these herpes-
viruses occurs and that viral activity in cells involved in
endometrium receptivity would have a negative effect
on human fertility.
Nevertheless, no evidence suggests so far that herpes-
virus infection has a negative influence on reproduction.
Indeed pre-pregnancy seropositivity to several viruses
protects against primary infection during pregnancy, de-
creasing the risk for pregnancy complications such as
preeclampsia [66]. Perhaps maternal infection by certain
(herpes) viruses even protects against other more harmful
infections.
The source of herpesviruses in semen has also yet to
be determined. It is commonly known that mumps virus
has the potential to infect the testis. Herpesviruses might
share this ability to infect testis tissue. Indeed, EBV and
HSV-1 and -2 have been isolated from human testis, and
murine CMV (MCMV) from mouse testis. Additionally,
HSV-2 and HCMV have been identified in prostate tis-
sue, but the effect of herpesvirus infection at these sites
is controversial [67].
Because of the risks of HCMV-mediated congenital de-
fects, the interest for HCMV-screening on donor semen is
increasing. Yet, it is not clear whether HCMV constitutes
a threat to the semen recipient, but since HCMV isolated
from semen is infectious [20,24,39], and since purification
of HCMV positive semen does not efficiently eliminate
the virus [22], the potential risk of HCMV transmission
during assisted reproductive techniques (ART) cannot be
ignored. Serology does not predict the presence of HCMV
in semen or cervix [32], therefore screening of donor
semen for HCMV DNA is necessary to prevent the use of
HCMV-contaminated sperm in ART. Unfortunately, this
would be costly, because shedding of herpesviruses fluctu-
ates, necessitating screening of all semen samples rather
than occasional checks [18].
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